Experience

Singular Genomics

• United States
• Biotechnology Research
• 100 - 200 Employee

• Staff Scientist

  • Oct 2022 - Present

  Lead Staff Scientist - In Situ Proteomics assay development, multiplex immunofluorescence, Histology. Also; Assay Architecture, Assay Integration, Lead Staff Scientist - In Situ Proteomics assay development, multiplex immunofluorescence, Histology. Also; Assay Architecture, Assay Integration,



SomaLogic

• United States
• Biotechnology
• 300 - 400 Employee

• Senior Scientist

  • Aug 2022 - Sep 2022

  Somalogic acquired Palamedrix in August 2022 Somalogic acquired Palamedrix in August 2022



Palamedrix (acquired by Somalogic)

• San Diego, California, United States

• Senior Scientist

  • Nov 2021 - Aug 2022

  - Brought a DNA nanostructure-based proteomic/ELISA platform from conception to formal development in 8 months - Established novel assays for the elimination of crosstalk in multiplex proteomic/ELISA assays and enhanced input-to-output response that surpasses capabilities of standard ELISA methods. - Designed, built, and assayed 2 generations of DNA nanostructures with multiple actuable parts for co-localized immunoassays, Limit of Blank reduction, and substantial multiplexing -… Show more - Brought a DNA nanostructure-based proteomic/ELISA platform from conception to formal development in 8 months - Established novel assays for the elimination of crosstalk in multiplex proteomic/ELISA assays and enhanced input-to-output response that surpasses capabilities of standard ELISA methods. - Designed, built, and assayed 2 generations of DNA nanostructures with multiple actuable parts for co-localized immunoassays, Limit of Blank reduction, and substantial multiplexing - Technical lead for formal development of co-localized DNA nanostructure-based proteomics Show less - Brought a DNA nanostructure-based proteomic/ELISA platform from conception to formal development in 8 months - Established novel assays for the elimination of crosstalk in multiplex proteomic/ELISA assays and enhanced input-to-output response that surpasses capabilities of standard ELISA methods. - Designed, built, and assayed 2 generations of DNA nanostructures with multiple actuable parts for co-localized immunoassays, Limit of Blank reduction, and substantial multiplexing -… Show more - Brought a DNA nanostructure-based proteomic/ELISA platform from conception to formal development in 8 months - Established novel assays for the elimination of crosstalk in multiplex proteomic/ELISA assays and enhanced input-to-output response that surpasses capabilities of standard ELISA methods. - Designed, built, and assayed 2 generations of DNA nanostructures with multiple actuable parts for co-localized immunoassays, Limit of Blank reduction, and substantial multiplexing - Technical lead for formal development of co-localized DNA nanostructure-based proteomics Show less



Wyss Institute at Harvard University

• United States
• Biotechnology Research
• 200 - 300 Employee

• Banting Fellow

  • Jul 2019 - Nov 2021

  Led the Church Lab efforts in developing technology for spatial and subcellular genomics and RNA sequencing of microbial communities using a combination of highly-efficient in situ enzymatics, in situ sequencing (sequencing-by-synthesis), spinning-disk fluorescence confocal microscopy, and hydrogel chemistry. Joint between the Wyss Institute and Dept. of Genetics at Harvard Medical School Led the Church Lab efforts in developing technology for spatial and subcellular genomics and RNA sequencing of microbial communities using a combination of highly-efficient in situ enzymatics, in situ sequencing (sequencing-by-synthesis), spinning-disk fluorescence confocal microscopy, and hydrogel chemistry. Joint between the Wyss Institute and Dept. of Genetics at Harvard Medical School



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Post Doc

  • Jan 2018 - Jul 2019

  With George Church - Developed new high-efficiency methods for NGS libraries performed in situ in a wide variety of cells and tissues, including microbial communities and brain organoids. With George Church - Developed new high-efficiency methods for NGS libraries performed in situ in a wide variety of cells and tissues, including microbial communities and brain organoids.



Gordon Research Seminar in New Antibiotic Drug Discovery, 2018

• Ventura, California

• Co-Chair

  • Mar 2016 - Mar 2018



McMaster University

• Canada
• Higher Education
• 700 & Above Employee

• Ph.D.

  • Jan 2011 - Nov 2017

  With: Dr. Gerry Wright. Thesis: Diversity and Evolution of Antibiotic Resistomes Investigated the evolution of antibiotic resistance using a combination of microbial genomics, protein and small molecule biochemistry, protein mutagenesis, and bioinformatics.

• Teaching Assistant

  • Sep 2011 - Apr 2017

  BIOCHEM 2L06 BIOCHEM 3P03 CHEMBIO 4GG9 (thesis mentor) BIOMEDDC 4A15 (thesis mentor)



TIPS

• Public Safety

• Editor

  • Jun 2015 - Dec 2015

  InfectionControl.tips was a publication that presents infectious disease research for the general public. InfectionControl.tips was a publication that presents infectious disease research for the general public.



University of Guelph

• Canada
• Higher Education
• 700 & Above Employee

• Thesis Student

  • Jan 2010 - Dec 2010

  Supervisor: Dr. Joseph Lam Biochemistry and molecular biology

• Research Assistant

  • Sep 2008 - Aug 2010

  Supervisor: Dr. Joseph Lam Biochemistry and molecular biology



National Research Council Canada / Conseil national de recherches Canada

• Canada
• Research Services
• 700 & Above Employee

• Carbohydrate Therapeutics

  • Sep 2009 - Dec 2009

  Biochemistry and biotechnology Biochemistry and biotechnology



Apotex Inc.

• Canada
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Formulations Development

  • Jan 2008 - Aug 2008

  Analytical chemistry Analytical chemistry